NO138530C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater

Info

Publication number
NO138530C
NO138530C NO741365A NO741365A NO138530C NO 138530 C NO138530 C NO 138530C NO 741365 A NO741365 A NO 741365A NO 741365 A NO741365 A NO 741365A NO 138530 C NO138530 C NO 138530C
Authority
NO
Norway
Prior art keywords
derivatives
preparation
therapeutic active
substituted pyrazolone
analogical procedure
Prior art date
Application number
NO741365A
Other languages
English (en)
Other versions
NO741365L (no
NO138530B (no
Inventor
Eike Moeller
Karl Meng
Egbert Wehinger
Harald Horstmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2319280A external-priority patent/DE2319280A1/de
Priority claimed from DE2363139A external-priority patent/DE2363139A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO741365L publication Critical patent/NO741365L/no
Publication of NO138530B publication Critical patent/NO138530B/no
Publication of NO138530C publication Critical patent/NO138530C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catalysts (AREA)
NO741365A 1973-04-17 1974-04-16 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater NO138530C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2319280A DE2319280A1 (de) 1973-04-17 1973-04-17 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2363139A DE2363139A1 (de) 1973-12-19 1973-12-19 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
NO741365L NO741365L (no) 1974-10-18
NO138530B NO138530B (no) 1978-05-12
NO138530C true NO138530C (no) 1978-09-20

Family

ID=25764996

Family Applications (1)

Application Number Title Priority Date Filing Date
NO741365A NO138530C (no) 1973-04-17 1974-04-16 Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater

Country Status (27)

Country Link
US (1) US3957814A (no)
JP (1) JPS5314071B2 (no)
AR (5) AR207444A1 (no)
AT (1) AT337176B (no)
BG (5) BG21405A3 (no)
CA (1) CA1034953A (no)
CH (5) CH605797A5 (no)
DD (1) DD113757A5 (no)
DK (1) DK136066C (no)
EG (1) EG11157A (no)
ES (3) ES425373A1 (no)
FI (1) FI57587C (no)
FR (1) FR2226172B1 (no)
GB (1) GB1429141A (no)
HK (1) HK70276A (no)
HU (1) HU168590B (no)
IE (1) IE39212B1 (no)
IL (1) IL44626A (no)
LU (1) LU69872A1 (no)
NL (1) NL177917C (no)
NO (1) NO138530C (no)
PH (1) PH14829A (no)
PL (1) PL96883B1 (no)
RO (2) RO69740A (no)
SE (1) SE408301B (no)
SU (2) SU539525A3 (no)
YU (1) YU104874A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056533A (en) * 1973-04-17 1977-11-01 Bayer Aktiengesellschaft Pyrazol-5-ones
DE2526467A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3306366A1 (de) * 1983-02-24 1984-08-30 Bayer Ag, 5090 Leverkusen Muzolimin enthaltende arzneimittel, deren verwendung und verfahren zu deren herstellung
US4663327A (en) * 1984-05-23 1987-05-05 Bayer Aktiengesellschaft 1-heteroaryl-4-aryl-pyrazolin-5-ones
JPH0730031B2 (ja) * 1986-04-02 1995-04-05 日産化学工業株式会社 ２―ピラゾリン―５―オン類の製造法
DE3738963A1 (de) * 1987-11-17 1989-05-24 Bayer Ag 3-aminopyrazolin-5-one
US5711929A (en) * 1989-05-06 1998-01-27 698638 Alberta Ltd. Purification of elemental sulphur
GB8912861D0 (en) * 1989-06-05 1989-07-26 Sherritt Gordon Ltd Purification of elemental sulphur
JPH079410Y2 (ja) * 1989-05-08 1995-03-06 株式会社アンレット 炭酸ガスレーザー光線発振器用ルーツブロワー
US5399565A (en) * 1990-07-17 1995-03-21 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof
US5300514A (en) * 1990-07-17 1994-04-05 Eli Lilly And Company Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof
EP0478195B1 (en) * 1990-09-21 1999-05-26 Rohm And Haas Company Dihydropyridazinones and pyridazinones as fungicides
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
NL279140A (no) * 1961-05-31

Also Published As

Publication number Publication date
CH605797A5 (no) 1978-10-13
AR207444A1 (es) 1976-10-08
FI57587C (fi) 1980-09-10
LU69872A1 (no) 1974-11-28
AR205272A1 (es) 1976-04-21
FR2226172B1 (no) 1978-07-28
IL44626A (en) 1980-01-31
FI57587B (fi) 1980-05-30
BG21857A3 (no) 1976-09-20
PL96883B1 (pl) 1978-01-31
US3957814A (en) 1976-05-18
IE39212L (en) 1974-10-17
HU168590B (no) 1976-06-28
AT337176B (de) 1977-06-10
ATA313274A (de) 1976-10-15
JPS5314071B2 (no) 1978-05-15
HK70276A (en) 1976-11-19
BG21218A3 (no) 1976-03-20
NL7405115A (no) 1974-10-21
NL177917C (nl) 1985-12-16
RO63749A (fr) 1979-01-15
DK136066B (da) 1977-08-08
ES447063A1 (es) 1977-06-16
CA1034953A (en) 1978-07-18
AR208192A1 (es) 1976-12-09
DK136066C (da) 1978-01-16
IL44626A0 (en) 1974-06-30
BG22821A3 (no) 1977-04-20
AR204951A1 (es) 1976-03-19
BG21405A3 (no) 1976-05-20
NO741365L (no) 1974-10-18
CH596172A5 (no) 1978-02-28
CH603592A5 (no) 1978-08-31
BG21217A3 (no) 1976-03-20
EG11157A (en) 1978-03-29
GB1429141A (en) 1976-03-24
YU104874A (en) 1982-02-28
FR2226172A1 (no) 1974-11-15
JPS5018466A (no) 1975-02-26
DD113757A5 (no) 1975-06-20
AR205271A1 (es) 1976-04-21
SU539525A3 (ru) 1976-12-15
CH605800A5 (no) 1978-10-13
AU6817474A (en) 1975-10-23
IE39212B1 (en) 1978-08-30
PH14829A (en) 1981-12-16
SU541430A3 (ru) 1976-12-30
NO138530B (no) 1978-05-12
ES447064A1 (es) 1977-09-16
SE408301B (sv) 1979-06-05
CH605801A5 (no) 1978-10-13
NL177917B (nl) 1985-07-16
ES425373A1 (es) 1976-09-01
RO69740A (ro) 1982-09-09

Similar Documents

Publication Publication Date Title
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO138805C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser
NO142155C (no) Fremgangsmaate til fremstilling av orale legemiddelpreparater
NO140854C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptid-amider
NO136793C (no) Analogifremgangsm}te til fremstilling av terapeutisk virksomme substituerte 1,2,4-triazolderivater.
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO138530C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-substituerte pyrazolon-(5)-derivater
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO139685C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO148644C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive sukkerderivater.
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO140978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO139439C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO136408C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser
NO140062C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner